|
Retinoids are chemically related to vitamin A and occur naturally within the body. Their role is to regulate the work of genes, helping cells to mature and divide. As a synthetic drug, retinoids have been shown to induce cancer cells to “self-destruct” by a process called apoptosis (programmed cell death). This type of cell death is a controlled sequence of events that eliminates cells in such a way as to avoid the release of harmful substances into the surrounding area.
Retinoids have been approved by the U.S. Food and Drug Administration (FDA) for cancer treatment, including Kaposi’s sarcoma and cutaneous T-cell lymphoma. It is being studied for several other applications, such as treating malignant and premalignant skin cancers, including basal cell carcinoma and squamous cell carcinoma.
The National Cancer Institute (NCI) is studying retinoids as part of its research into chemoprevention. Chemoprevention uses natural or synthetic substances to reduce the risk of cancer or the possibility of a recurrence. Retinoids may be able to prevent abnormal cell growths, or dysplasias, from developing into cancer. Because they are related to or derived from vitamin A, retinoids have an antioxidant effect. Antioxidants are substances that may protect cells from the damage caused by unstable molecules known as free radicals. Damage caused by free radicals may lead to cancer.
Retinoids are being studied to determine their ability to treat and prevent numerous cancers, including cancers of the head and neck, breast, lung and prostate.
Retinoid therapy can cause significant side effects, including the risk of birth defects. In addition, it is important for patients who take retinoids to not give blood during treatment or for three years after discontinuing retinoid therapy to prevent a pregnant woman from receiving retinoid–tainted blood.
Retinoids come in several forms and use will vary depending on the condition. They are administered according to the condition that is being treated. For example, many retinoids are available in a topical gel, which is commonly used to treat severe acne, leukoplakia and Kaposi’s sarcoma. Retinoids taken orally have been used to treat basal cell carcinoma, basal cell nevus syndrome and xeroderma pigmentosa, a rare genetic defect that affects the skin. Retinoid dosage depends on the particular medication and condition. As with all medications, it is important that a patient receive directions by their physician and/or pharmacist prior to starting any retinoid therapy.
|